How vaccine safety is monitored in SA

How vaccine safety is monitored in SA

Strict monitoring and surveillance systems for the safety of all vaccines, including those for COVID-19, are in place during vaccine trials as well as once vaccines are rolled out more widely. Adele Baleta takes a look at how vaccine-related adverse events are monitored in South Africa.

Read More

Editorial: Pieces finally slotting into place for mass vaccination in SA

Editorial: Pieces finally slotting into place for mass vaccination in SA

Within the next month or so we will be switching gears from the comparatively small-scale trial run of Sisonke to a full-on mass vaccination programme. As with the onset of a new wave of infections, this presents a dramatic shift in the pandemic and our response to it – although in this case, the shift is finally a good thing, writes Spotlight editor Marcus Low.

Read More

Health in 2021: Spotlight’s top 12 questions

Health in 2021: Spotlight’s top 12 questions

While COVID-19 will continue to make headlines for some time, 2021 will also be a critical year for healthcare reforms in South Africa and for various aspects of the country’s HIV and TB response. These are Spotlight’s top 12 healthcare questions for the year.

Read More

COVID-19: Millions of injection devices will be needed for vaccines

COVID-19: Millions of injection devices will be needed for vaccines

The delivery of a safe and effective COVID-19 vaccine once it becomes available in South Africa will be a complex and costly logistical exercise. Acquiring enough injection devices is part of crucial logistical planning to ensure rapid, equitable access to COVID-19 vaccines. Adele Baleta reports.

Read More

COVID-19: What local vaccine production actually means

COVID-19: What local vaccine production actually means

South Africa is set to produce its first vaccine in 25 years, but it won’t be a COVID-19 jab. Plans are however in place to “fill and finish” COVID-19 vaccines in South Africa. Laura Lopez Gonzalez has the details.

Read More

Where are we in the race for a HIV vaccine?

Where are we in the race for a HIV vaccine?

While progress in the race for effective COVID-19 vaccines has been rapid and impressive, an effective HIV vaccine remains elusive. As part of Spotlight’s World AIDS Day 2020 coverage, Kathryn Cleary asks two of South Africa’s top vaccine researchers to update us on where we are in the race for an HIV vaccine.

Read More

Opinion: Why fixing South Africa’s patent laws is necessary in the fight against HIV

Opinion: Why fixing South Africa’s patent laws is necessary in the fight against HIV

In 2018, Cabinet adopted a new intellectual property policy for South Africa, but as yet the policy has not led to any change in the country’s patent laws. Amending these laws as soon as possible is critical to both the COVID-19 and HIV response, argues Umunyana Rugege.

Read More

COVID-19: How vaccine registration will work in SA

COVID-19: How vaccine registration will work in SA

Before any COVID-19 vaccines can be made available in South Africa, they must be authorised by South Africa’s medicines regulator—the South African Health Products Regulatory Authority (SAHPRA). Catherine Tomlinson explores how SAHPRA is preparing to review and authorise the use of COVID-19 vaccines in the country and the different authorisation approaches they may use.

Read More

COVID-19: No deal yet to access “90% effective” vaccine tested in South Africa

COVID-19: No deal yet to access “90% effective” vaccine tested in South Africa

The head of the South African arm of a key COVID-19 vaccine clinical trial is “full of pride” for the teams’ part in the research which has shown the vaccine candidate to be more than 90% effective according to early findings released this week. It however remains unclear whether the vaccine will be available in South Africa once registered. Adele Baleta reports.

Read More

IN-DEPTH: The slow motion race for a TB vaccine

IN-DEPTH: The slow motion race for a TB vaccine

In recent months, the world has seen unprecedented investment in new vaccines. Yet, while a COVID-19 vaccine proven to be safe and effective may be less than a year away, a new tuberculosis vaccine might only be ready to be rolled out in a decade, despite a massive head start over COVID-19. Amy Green takes a closer look at the race for a new vaccine for the world’s top infectious disease killer.

Read More

What we know about vaccine hesitancy in South Africa

What we know about vaccine hesitancy in South Africa

A recent global online survey suggests that more than a third of South Africans would not want a COVID-19 vaccine if and when it becomes available. Adele Baleta reports on vaccine hesitancy in South Africa.

Read More

SA to take part in two more COVID-19 vaccine trials

SA to take part in two more COVID-19 vaccine trials

South Africa is consolidating its place in the race for a COVID-19 vaccine with its participation starting from next month in two new international trials of vaccine candidates. Adele Baleta reports.

Read More